Kenneth J Zuerblis's Net Worth
-$80.6 Thousand
Who is Kenneth J Zuerblis?
Kenneth J Zuerblis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, SAVIENT PHARMACEUTICALS INC, XTL BIOPHARMACEUTICALS LTD, STEMLINE THERAPEUTICS INC, IMCLONE SYSTEMS INC, and ENZON PHARMACEUTICALS INC.
SEC CIK
Kenneth J Zuerblis's CIK is 0001007923
Past Insider Trading and Trends
2011 was Kenneth J Zuerblis's most active year for acquiring shares with 7 total transactions. Kenneth J Zuerblis's most active month to acquire stocks was the month of May. 2020 was Kenneth J Zuerblis's most active year for disposing of shares, totalling 3 transactions. Kenneth J Zuerblis's most active month to dispose stocks was the month of May. 2011 saw Kenneth J Zuerblis paying a total of $1,167,849.60 for 327,000 shares, this is the most they've acquired in one year. In 2008 Kenneth J Zuerblis cashed out on 80,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
InvestorKenneth J Zuerblis owns 9,167 units of Common Stock. In the year 2010 Kenneth J Zuerblis acquired a total of 9,167 shares in IMMUNOMEDICS INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +119.99% | 5K |
—
|
—
| 9.17K |
Dec 7
| |||
Form 4
|
∞
| 4.17K |
—
|
—
| 4.17K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SAVIENT PHARMACEUTICALS INC No price found
EVP, Chief Financial OfficerKenneth J Zuerblis owns 7,000 units of Common Stock, $.01 par value per share. In the year 2011 Kenneth J Zuerblis acquired a total of 7,000 shares in SAVIENT PHARMACEUTICALS INC at a cost of $24,849.60.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +40.00% | 2K |
$2.35 | $4,690.00 | 7K |
Nov 18
| |||
Form 4
|
∞
| 5K |
$4.03 | $20,159.60 | 5K |
Sep 14 - Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
| No matching records found | |||||||||
XTL BIOPHARMACEUTICALS LTD (XTLB) Snapshot price: $0.9131
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STEMLINE THERAPEUTICS INC No price found
InvestorKenneth J Zuerblis owns 31,289 units of Common Stock. From 2013 to 2020 Kenneth J Zuerblis acquired a total of 52,158 shares in STEMLINE THERAPEUTICS INC at a cost of $59,184.84, Kenneth also disposed a total of 60,121 shares of STEMLINE THERAPEUTICS INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -60.12K |
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +33.24% | 15K |
—
|
—
| 60.12K |
Jun 25
| |||
Form 4
| +41.17% | 13.16K |
—
|
—
| 45.12K |
Jun 21
| |||
Form 4
| +45.53% | 10K |
—
|
—
| 31.96K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +83.59% | 10K |
—
|
—
| 21.96K |
Jun 23
| |||
Form 4
| +9.12% | 1K |
$11.14 | $11,142.90 | 11.96K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +8.03% | 3K |
$16.12 | $48,041.94 | 40.35K |
May 29 - May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMCLONE SYSTEMS INC No price found
SVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||